Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Other Non-Current Liabilities (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Other Non-Current Liabilities for 7 consecutive years, with $244000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 14.69% to $244000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $244000.0 through Dec 2025, down 14.69% year-over-year, with the annual reading at $244000.0 for FY2025, 14.69% down from the prior year.
  • Other Non-Current Liabilities hit $244000.0 in Q4 2025 for BridgeBio Pharma, down from $679000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $28.6 million in Q2 2022 to a low of $244000.0 in Q4 2025.
  • Historically, Other Non-Current Liabilities has averaged $11.8 million across 5 years, with a median of $11.7 million in 2021.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 315.16% in 2021 and later plummeted 96.8% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $22.1 million in 2021, then increased by 20.73% to $26.6 million in 2022, then crashed by 78.85% to $5.6 million in 2023, then tumbled by 94.92% to $286000.0 in 2024, then decreased by 14.69% to $244000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for BBIO at $244000.0 in Q4 2025, $679000.0 in Q3 2025, and $545000.0 in Q2 2025.